ZHANG; Tianyuan

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHANG; Tianyuan.The latest application filed is for "use of beta-glucan extract in immunopotentiation of an avian animal".

Company Profile

3.5.10

ZHANG; Tianyuan - Beijing CN
Zhang; Tianyuan - Urbana IL
Zhang; Tianyuan - Edison NJ
Zhang; Tianyuan - Gurnee IL US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Beta-glucan Extract In Immunopotentiation Of An Avian Animal App 20210236536 - HE; Cheng ; et al.	2021-08-05
Method And System For Identifying Recipients Of A Reward Associated With A Conversion App 20190370857 - Boyapally; Yugandhar Reddy ; et al.	2019-12-05
Method And System For Identifying Recipients Of A Reward Associated With A Conversion App 20190370842 - Boyapally; Yugandhar Reddy ; et al.	2019-12-05
Method And System For Identifying Recipients Of A Reward Associated With A Conversion App 20190370855 - Boyapally; Yugandhar Reddy ; et al.	2019-12-05
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease Grant 10,414,775 - Caldwell , et al. Sept	2019-09-17
Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease App 20190218224 - Caldwell; John P. ; et al.	2019-07-18
Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome Grant 8,748,627 - Gu , et al. June 10, 2	2014-06-10
Antibacterial compounds Grant 8,163,769 - Anderson , et al. April 24, 2	2012-04-24
Novel Acetyl-coa Carboxylase (acc) Inhibitors And Their Use In Diabetes, Obesity And Metabolic Syndrome App 20070225332 - Gu; Yu Gui ; et al.	2007-09-27
Thienopyridones as AMPK activators for the treatment of diabetes and obesity App 20060287356 - Iyengar; Rajesh R. ; et al.	2006-12-21
Thienopyridones as AMPK activators for the treatment of diabetes and obesity Grant 7,119,205 - Iyengar , et al. October 10, 2	2006-10-10
Novel acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome App 20060178400 - Beutel; Bruce A. ; et al.	2006-08-10
Thienopyridones as AMPK activators for the treatment of diabetes and obesity App 20050038068 - Iyengar, Rajesh R. ; et al.	2005-02-17
Antibacterial compounds App 20030232818 - Anderson, David ; et al.	2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.